Pierre Fabre Laboratories. (3/12/25). "Press Release: Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership". Castres, Cambridge, MA & Basel. |
2025-03-12 |
Corden Pharma International GmbH. (3/5/25). "Press Release: CordenPharma Expands Peptide Platform with >€500m Greenfield Facility Construction in the Basel Region of Switzerland". Basel. |
2025-03-05 |
Callio Therapeutics. (3/3/25). "Press Release: Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept". Seattle, WA & Singapore. |
2025-03-03 |
SparingVision SAS. (3/3/25). "Press Release: SparingVision Appoints Anjeza Gjino as Chief Financial Officer". Paris. |
2025-03-03 |
Qiagen N.V.. (3/3/25). "Press Release: Qiagen Takes Legal Action to Defend QuantiFERON Intellectual Property and Protect Innovations in Latent Tuberculosis Testing". Venlo. |
2025-03-03 |
Enveda. (2/26/25). "Press Release: Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M". Boulder, CO. |
2025-02-26 |
Fuse Vectors ApS. (2/25/25). "Press Release: Fuse Vectors Secures $5.2m to Advance Cell-free Gene therapy Technology, Led by HCVC". Copenhagen. |
2025-02-25 |
Evotec SE. (2/25/25). "Press Release: Evotec Announces Change in Management Board". Lüneburg. |
2025-02-25 |
Medincell S.A.. (2/19/25). "Press Release: Medincell Announces Successful c.€43 Million Global Offering [Not for US, AU, ZA, CA or JP]". |
2025-02-19 |
Newronika S.p.A.. (2/13/25). "Press Release: Newronika Closes €13.6 Million Series B Financing to Accelerate Development of Adaptive DBS Platform". Milan. |
2025-02-13 |
Bio-Rad Laboratories, Inc.. (2/13/25). "Press Release: Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies". Hercules, CA. |
2025-02-13 |
Latent Labs Ltd.. (2/13/25). "Press Release: Latent Labs Secures $50M in Funding to Realize the Potential of AI-powered, Programmable Biology". London & San Francisco, CA. |
2025-02-13 |
OSE Immunotherapeutics S.A.. (1/29/25). "Press Release: OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy". Nantes & Paris. |
2025-01-29 |
TME Pharma N.V.. (1/29/25). "Press Release: TME Pharma Announces Collaboration with Aimed Analytics for AI-Driven Drug Discovery and Optimization". Berlin. |
2025-01-29 |
Stryker. (1/28/25). "Press Release: Stryker Announces Definitive Agreement for the Sale of its U.S. Spinal Implants Business and Plans to Sell Related International Business". Portage, MI. |
2025-01-28 |
Quibim S.L.. (1/28/25). "Press Release: Quibim Announces $50 Million in Series A Financing, Led by Asabys and Buenavista, to Revolutionize Precision Medicine with AI-Powered Imaging Biomarkers". Valencia & New York, NY. |
2025-01-28 |
Forbion Capital Partners. (1/27/25). "Press Release: Forbion BioEconomy Fund I Surpasses €150 Million Target, Raising €164.5 Million with Strong Institutional LP Support". Naarden. |
2025-01-27 |
Median Technologies S.A.. (1/24/25). "Press Release: Median Technologies Securing up to €47.5 Million to Support AI Lung Cancer Diagnostic Eyonis Regulatory Filings and Commercialization in U.S. and EU". Sophia Antipolis. |
2025-01-24 |
Pharming Group N.V.. (1/21/25). "Press Release: Pharming to Nominate Biopharmaceutical Leader Fabrice Chouraqui as New Executive Director and Chief Executive Officer". Leiden. |
2025-01-21 |
SGS S.A.. (1/15/25). "Press Release: Statement. Following Recent Media Commentary SGS Indicates that It Is in Discussions with Bureau Veritas Regarding a Potential Business Combination". |
2025-01-15 |
Bioptimus SAS. (1/14/25). "Press Release: Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology". |
2025-01-14 |
Cube Biotech GmbH. (1/13/25). "Press Release: Cube Biotech, Pioneer in Membrane Protein Production and Purification Technologies, Completes a Transformational Transaction with the Acquisition of IBA Lifesciences". Monheim. |
2025-01-13 |
bioMérieux S.A.. (1/13/25). "Press Release: bioMérieux Strengthens Its Point of Care Presence with the Acquisition of the Immunoassay Start-up SpinChip". Marcy l’Étoile. |
2025-01-13 |
bioMérieux S.A.. (1/13/25). "Press Release: SpinChip Diagnostics to be Acquired by bioMérieux". Oslo. |
2025-01-13 |
Normunity, Inc.. (1/13/25). "Press Release: Normunity Closes $75 million Series B Financing to Advance Lead Drug Program into the Clinic and Broaden Pipeline of Novel Anti-cancer Therapies Targeting Untapped Drug Mechanisms". Boston, MA & New Haven, CT. |
2025-01-13 |
bioMérieux S.A.. (1/13/25). "Press Release: bioMérieux to Present at the 43rd Annual J.P. Morgan HealthCare Conference". Marcy l’Étoile. |
2025-01-13 |
Astraveus SAS. (1/9/25). "Press Release: Astraveus Announces World First End-to-End Production of CAR-T Cells Using Microfluidic Technology". Paris. |
2025-01-09 |
Coave Therapeutics (Horama S.A.). (1/9/25). "Press Release: Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines". Paris. |
2025-01-09 |
Argobio SAS. (1/7/25). "Press Release: Next-generation RNA Company Inverna Therapeutics Launched by Argobio and University of Southern Denmark". Odense. |
2025-01-07 |
Sanofi S.A.. (12/19/24). "Press Release: Jean-Paul Kress to Join Sanofi’s Board of Directors". Paris. |
2024-12-19 |
XGen Venture SGR S.p.A.. (12/19/24). "Press Release: XGen Venture Announces Final Closing of €180M ($190M) Life Sciences Fund". Milan. |
2024-12-19 |
Gilde Healthcare Partners. (12/16/24). "Press Release: Gilde Healthcare Invests alongside Capital A in Tromp Medical to Accelerate International Growth in the Medical Imaging Market". Utrecht. |
2024-12-16 |
Andera Partners. (12/12/24). "Press Release: New York Life Investments and Its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners". New York, NY, Paris & Brussels. |
2024-12-12 |
EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million". |
2024-12-11 |
Siemens Healthineers AG. (12/10/24). "Press Release: Siemens Healthineers Acquires Advanced Accelerator Applications Molecular Imaging". |
2024-12-10 |
Aqemia SAS. (12/10/24). "Press Release: Aqemia Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK". Paris & London. |
2024-12-10 |
Citryll B.V.. (12/9/24). "Press Release: Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders". Oss. |
2024-12-09 |
Sartorius AG. (12/6/24). "Press Release: Michael Grosse to Succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG". Göttingen. |
2024-12-06 |
Muna Therapeutics ApS. (12/5/24). "Press Release: Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease". Copenhagen. |
2024-12-05 |
TME Pharma N.V.. (12/4/24). "Press Release: (CORRECTING and REPLACING) TME Pharma Announces Corporate Strategy Update and Upcoming €2.6 Million Guaranteed Financing With Intention to Launch Public Offer Open Only to Shareholders to Enable Completion of T |
2024-12-04 |
Ipsen S.A.. (12/3/24). "Press Release: Ipsen and Biomunex Announce Exclusive Global Licensing Agreement for First-in-Class MAIT Cell Engager in Immuno-oncology". Paris. |
2024-12-03 |
Evotec SE. (11/29/24). "Press Release: Evotec Announces Change in Management Board. Dr Craig Johnstone Steps Down as Chief Operating Officer Effective 31 December 2024". Hamburg. |
2024-11-29 |
Adragos Pharma GmbH. (11/25/24). "Press Release: Adragos Pharma Acquires Baccinex – a Leading Swiss Sterile Fill-Finish Expert". Munich & Courroux. |
2024-11-25 |
[iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
Andera Partners. (11/13/24). "Press Release: Andera Partners Continues Its International Expansion and Announces the Opening of a Madrid Office". Paris & Madrid. |
2024-11-13 |
Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel. |
2024-11-12 |
TME Pharma N.V.. (10/31/24). "Press Release: TME Pharma Awarded €2.4 Million German Federal Grant to Support NOX-A12 Phase 2 Trial in Brain Cancer". Berlin. |
2024-10-31 |
Innate Pharma S.A.. (10/14/24). "Press Release: Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board". |
2024-10-14 |
Purespring Therapeutics Ltd.. (10/9/24). "Press Release: Purespring Therapeutics Raises £80/$105 Million in a Series B Financing to Transform the Treatment of Kidney Diseases". London. |
2024-10-09 |
Mérieux NutriSciences Corporation. (10/7/24). "Press Release: Mérieux NutriSciences Enters Agreement to Acquire Worldwide Food Testing Business of Bureau Veritas". Chicago, IL. |
2024-10-07 |
Kurma Partners. (10/3/24). "Press Release: Kurma Partners Achieves First Close of New EUR 250 Million Biofund IV". Paris. |
2024-10-03 |
TME Pharma N.V.. (9/30/24). "Press Release: TME Pharma Announces Appointment of Alexandra Glucksmann to Supervisory Board". Berlin. |
2024-09-30 |
Sequentia Biotech S.L.. (9/27/24). "Press Release: Sequentia Biotech Secures €10 Million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications". Barcelona. |
2024-09-27 |
Flash Therapeutics SAS (c/b/a Flash BioSolutions). (9/25/24). "Press Release: Flash BioSolutions Launches GMP Production of Revolutionary mRNA Technology for Next-generation Vaccines and Therapies". Toulouse. |
2024-09-25 |
Genespire S.r.l.. (9/25/24). "Press Release: Genespire Raises €46.6 Million (~$52 Million) in a Series B Round to Advance Its First Pediatric in-vivo Gene Therapy into the Clinic". Milan. |
2024-09-25 |
High-Tech Gründerfonds Management GmbH. (9/16/24). "Press Release: Symphera Secures €2.4 Million in Seed Financing to Revolutionize Laparoscopic Surgery". Munich. |
2024-09-16 |
Genespire S.r.l.. (9/12/24). "Press Release: Genespire Appoints Karen Aiach-Pignet as Chief Executive Officer". Milan. |
2024-09-12 |
Novameat Tech SL. (9/12/24). "Press Release: Novameat Raises €17.4M Oversubscribed Series A Round Led by Sofinnova Partners and Forbion". Barcelona. |
2024-09-12 |
Abolis Biotechnologies SAS. (9/12/24). "Press Release: Abolis Biotechnologies Secures 35 Mio. Euro from International Consortium of Industrials and Funds". Èvry-Courcouronnes. |
2024-09-12 |
Sofinnova Partners. (9/10/24). "Press Release: Sofinnova Partners Appoints Karl Naegler as Partner". Paris. |
2024-09-10 |
Alentis Therapeutics AG. (9/3/24). "Press Release: Alentis Appoints Jonathan Freve CFO". Basel. |
2024-09-03 |
Evotec SE. (9/3/24). "Press Release: Evotec Announces Change in Management Board. Dr Matthias Evers Steps Down as Chief Business Officer Effective 01 October 2024". Hamburg. |
2024-09-03 |
Caresyntax. (8/15/24). "Press Release: Caresyntax Raises $180 Million Funding to Accelerate Growth and Adoption of Precision Surgery". San Francisco, CA & Berlin. |
2024-08-15 |
Marinomed Biotech AG. (8/14/24). "Press Release: Marinomed Biotech AG Aims for Financial Reorganization by Restructuring Proceedings without Self-administration". Korneuburg. |
2024-08-14 |
MeiraGTx Holdings plc. (8/12/24). "Press Release: MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi". London & New York, NY. |
2024-08-12 |
Balderton Capital. (8/12/24). "Press Release: Balderton Announces $1.3B in New Funds to Back Europe’s Top Entrepreneurs as They Build World-changing Businesses". |
2024-08-12 |
PolyPeptide Group AG. (8/8/24). "Press Release: PolyPeptide Appoints Chief Commercial Officer". Baar. |
2024-08-08 |
Recursion Pharmaceuticals, Inc.. (8/8/24). "Press Release: Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities". Salt Lake City, UT & Oxford. |
2024-08-08 |
Bruker Corporation. (8/7/24). "Press Release: Bruker Announces Strategic Minority Investment in Novalix". |
2024-08-07 |
Carbios S.A.. (8/6/24). "Press Release: Carbios and FCC Environment Announce Joint Project to Establish UK-based PET Biorecycling Facility Using Carbios’ Licensed Technology". Clermont-Ferrand & Doncaster. |
2024-08-06 |
Valneva S.E.. (8/1/24). "Press Release: Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World’s Most Clinically Advanced Tetravalent Shigella Vaccine Candidate". Saint-Herblain & Schlieren. |
2024-08-01 |
Micropep Technologies SAS. (7/25/24). "Press Release: Micropep Raises $29M in Series B Funding and Unveils Krisalix, its Proprietary Discovery Platform". Boston, MA. |
2024-07-25 |
Deepc GmbH. (7/24/24). "Press Release: Deepc Closes Series A Extension to Accelerate Global Deployment of Healthcare AI, Bringing Total Funding to $30m". Munich. |
2024-07-25 |
Kadans Science Partner. (7/24/24). "Press Release: Kadans Science Partner Commences Work on New Purpose-built Wet Lab Facilities at Merlin Place, North Cambridge". Cambridge. |
2024-07-24 |
Valneva S.E.. (7/22/24). "Press Release: CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine". Oslo & Saint-Herblain. |
2024-07-22 |
TME Pharma N.V.. (7/22/24). "Press Release: TME Pharma Announces Strategic Plan to Externalize and Monetize Second Clinical Stage Asset NOX-E36". Berlin. |
2024-07-22 |
Catalym GmbH. (7/16/24). "Press Release: Catalym Announces New Financing of $150M to Support Broad Phase 2b Development Program for Visugromab". Munich. |
2024-07-16 |
Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA. |
2024-07-16 |
Affluent Medical S.A.. (7/12/24). "Press Release: Affluent Medical Signs Agreements for Mitral Valve Technologies with EUR 15M Upfront Payment". Rotterdam. |
2024-07-12 |
Bioptimus SAS. (7/11/24). "Press Release: Bioptimus Launches H-optimus-0, the World’s Largest Open-source AI Foundation Model for Pathology". |
2024-07-11 |
Ipsen S.A.. (7/11/24). "Press Release: Ipsen and Foreseen Biotechnology Announce Exclusive Global Licensing Agreement for Antibody-Drug Conjugate with First-in-Class Potential". Paris. |
2024-07-11 |
Endoron Medical Ltd.. (7/9/24). "Press Release: Endoron Medical Raises $10 Million in Series A Funding Led by Sofinnova Partners to Accelerate the Validation of Its AAA EndoStapling Solution Aortoseal". Tel Aviv. |
2024-07-09 |
SciRhom GmbH. (7/9/24). "Press Release: SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases". Munich. |
2024-07-09 |
Myricx Pharma Ltd.. (7/8/24). "Press Release: Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development". London. |
2024-07-08 |
Evotec SE. (7/8/24). "Press Release: Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz". Hamburg & Seattle, WA. |
2024-07-08 |
Touchlight Genetics Ltd.. (7/2/24). "Press Release: Touchlight and LenioBio Collaborate to Accelerate Development of Protein Therapeutics for Pandemic Response". Hampton & Düsseldorf. |
2024-07-02 |
Valneva S.E.. (7/1/24). "Press Release: Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain. |
2024-07-01 |
CatSci Ltd.. (6/25/24). "Press Release: CatSci Announces Strategic Acquisition of Reach Separations to Offer End-To-End Separation Science Support from Discovery to Manufacture". |
2024-06-25 |
Allecra Therapeutics GmbH. (6/24/24). "Press Release: Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic Exblifeb in Gulf Cooperation Council countries and South Africa". Saint-Louis, Weil am Rhein |
2024-06-24 |
Wacker Chemie AG. (6/19/24). "Press Release: Wacker & CordenPharma Enter Pandemic Readiness on 1 June 2024 After Successful Expansion & Qualification". Munich, Halle (Saale) & Basel. |
2024-06-19 |
TME Pharma N.V.. (6/18/24). "Press Release: TME Pharma Announces Results of Successful Capital Increase With €2.35 Million Raised". Berlin. |
2024-06-18 |
AdBio Partners SAS. (6/18/24). "Press Release: Inserm Transfert and AdBio Partners Launch AndzonBio". Paris. |
2024-06-18 |
Evotec SE. (6/12/24). "Press Release: Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb". Hamburg. |
2024-06-12 |
Adcytherix SAS. (6/11/24). "Press Release: Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates". Marseille. |
2024-06-11 |
Tacalyx GmbH. (6/11/24). "Press Release: Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs". Berlin. |
2024-06-11 |
Evotec SE. (6/10/24). "Press Release: Results of the Annual General Meeting 2024". Hamburg. |
2024-06-10 |
Ipsen S.A.. (6/10/24). "Press Release: Ipsen’s Iqirvo Receives U.S. FDA Accelerated Approval as a First-in-Class PPAR Treatment for Primary Biliary Cholangitis". Paris. |
2024-06-10 |
AdBio Partners SAS. (6/4/24). "Press Release: AdBio Partners Promotes Emma Gasol to Partner". Paris & Barcelona. |
2024-06-04 |
Evotec SE. (5/30/23). "Press Release: Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases". Hamburg. |
2024-05-30 |
Merck & Co., Inc.. (5/29/24). "Press Release: Merck to Acquire EyeBio". Rahway, NJ & New York, NY. |
2024-05-29 |